Local Recurrence Following Resection of Intermediate-High Risk Nonmetastatic Renal Cell Carcinoma: An Anatomical Classification and Analysis of the ASSURE (ECOG-ACRIN E2805) Adjuvant Trial-Reference-Cited by-同舟云学术

Local Recurrence Following Resection of Intermediate-High Risk Nonmetastatic Renal Cell Carcinoma: An Anatomical Classification and Analysis of the ASSURE (ECOG-ACRIN E2805) Adjuvant Trial

Published:2020-04 Issue:4 Volume:203 Page:684-689
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Lee Ziho¹,Jegede Opeyemi A.²,Haas Naomi B.³,Pins Michael R.⁴,Messing Edward M.⁵,Manola Judith²,Wood Christopher G.⁶,Kane Christopher J.⁷,Jewett Michael A. S.⁸,Flaherty Keith T.⁹,Dutcher Janice P.¹⁰,DiPaola Robert S.¹¹,Uzzo Robert G.¹

Affiliation:

1. Fox Chase Cancer Center-Temple Health System, Philadelphia, Pennsylvania

2. ECOG-ACRIN Biostatistics Center, Dana-Farber Cancer Institute, Boston, Massachusetts

3. University of Pennsylvania, Philadelphia, Pennsylvania

4. Advocate Lutheran General Hospital, Park Ridge, Illinois

5. University of Rochester, Rochester, New York

6. MD Anderson Cancer Center, Houston, Texas

7. University of California-San Diego, La Jolla, California

8. University of Toronto, Toronto, Ontario, Canada

9. Massachusetts General Hospital Cancer Center, Boston, Massachusetts

10. Cancer Research Foundation of New York, Chappaqua, New York

11. University of Kentucky College of Medicine, Lexington, Kentucky